Judging the clinical suitability of analytical performance of cardiac troponin assays
Abstract: New millennium diagnostic criteria for acute myocardial infarction precipitated a revolutionary shift from an approach based primarily on electrocardiography and clinical symptoms to a strategy based on biomarkers, and preferably cardiac troponins (cTn) I and T. In the last 20 years, clinical recommendations have strengthened the role of cTn and led to the development of highly sensitive (hs-cTn) assays, which are now leading players in all current clinical practice guidelines. To optimize the clinical use of these hs-cTn assays, focus on their analytical aspects has become increasingly important, emphasizing the need for the establishment of suitable analytical performance by the definition and implementation of appropriate specifications. An accurate estimate of measurement uncertainty, together with the acquisition of the highest analytical quality when very low concentrations of hs-cTn are measured, are essential requirements and should represent a practical laboratory standard in assuring optimal clinical use. Additional goals for further improving the quality of laboratory information should be the establishment of robust data concerning biological variation of cTn and the resolution of practical challenges opposed to the harmonization of cTn I results obtained by differing commercial measuring systems.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Judging the clinical suitability of analytical performance of cardiac troponin assays ; volume:61 ; number:5 ; year:2023 ; pages:801-810 ; extent:10
Clinical chemistry and laboratory medicine ; 61, Heft 5 (2023), 801-810 (gesamt 10)
- Urheber
-
Krintus, Magdalena
Panteghini, Mauro
- DOI
-
10.1515/cclm-2023-0027
- URN
-
urn:nbn:de:101:1-2023033114212539650214
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Krintus, Magdalena
- Panteghini, Mauro
Ähnliche Objekte (12)
High sensitivity cardiac troponin assays
Use of Cardiac Troponin Assays in Hemodialysis Patients
Terminology of cardiac troponin assays and data censoring
Evaluation of analytical performance of the Pathfast® cardiac troponin I
Discovery of novel cardiac troponin activators using fluorescence polarization-based high throughput screening assays
High sensitivity cardiac troponin assays, rapid myocardial infarction rule-out algorithms, and assay performance
Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers
Cardiac troponin - friend or foe?
High incidence of discrepancies in new Siemens assay – a comparison of cardiac troponin I assays
The European Biological Variation Study (EuBIVAS): weekly biological variation of cardiac troponin I estimated by the use of two different high-sensitivity cardiac troponin I assays
Cardiac troponin I levels in canine pyometra
Cardiac Troponin I elevation after epileptic seizure
High sensitivity cardiac troponin assays
Use of Cardiac Troponin Assays in Hemodialysis Patients
Terminology of cardiac troponin assays and data censoring
Evaluation of analytical performance of the Pathfast® cardiac troponin I
Discovery of novel cardiac troponin activators using fluorescence polarization-based high throughput screening assays
High sensitivity cardiac troponin assays, rapid myocardial infarction rule-out algorithms, and assay performance
Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers
Cardiac troponin - friend or foe?
High incidence of discrepancies in new Siemens assay – a comparison of cardiac troponin I assays
The European Biological Variation Study (EuBIVAS): weekly biological variation of cardiac troponin I estimated by the use of two different high-sensitivity cardiac troponin I assays
Cardiac troponin I levels in canine pyometra
Cardiac Troponin I elevation after epileptic seizure
High sensitivity cardiac troponin assays
Use of Cardiac Troponin Assays in Hemodialysis Patients
Terminology of cardiac troponin assays and data censoring
Evaluation of analytical performance of the Pathfast® cardiac troponin I
Discovery of novel cardiac troponin activators using fluorescence polarization-based high throughput screening assays
High sensitivity cardiac troponin assays, rapid myocardial infarction rule-out algorithms, and assay performance
Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers
Cardiac troponin - friend or foe?
High incidence of discrepancies in new Siemens assay – a comparison of cardiac troponin I assays
The European Biological Variation Study (EuBIVAS): weekly biological variation of cardiac troponin I estimated by the use of two different high-sensitivity cardiac troponin I assays
Cardiac troponin I levels in canine pyometra